Europe Solid Tumors Drugs Market Report 2016

Europe Solid Tumors Drugs Market Report 2016

1 Solid Tumors Drugs Overview

1.1 Product Overview and Scope of Solid Tumors Drugs

1.2 Classification of Solid Tumors Drugs

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Solid Tumors Drugs

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 Solid Tumors Drugs Market by Countries

1.4.1 Germany Status and Prospect (2011-2021)

1.4.2 France Status and Prospect (2011-2021)

1.4.3 UK Status and Prospect (2011-2021)

1.4.4 Russia Status and Prospect (2011-2021)

1.4.5 Italy Status and Prospect (2011-2021)

1.4.6 Spain Status and Prospect (2011-2021)

1.4.7 Benelux Status and Prospect (2011-2021)

1.5 Europe Market Size (Value and Volume) of Solid Tumors Drugs (2011-2021)

1.5.1 Europe Solid Tumors Drugs Sales and Growth Rate (2011-2021)

1.5.2 Europe Solid Tumors Drugs Revenue and Growth Rate (2011-2021)

2 Europe Solid Tumors Drugs by Manufacturers, Type and Application

2.1 Europe Solid Tumors Drugs Market Competition by Manufacturers

2.1.1 Europe Solid Tumors Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Europe Solid Tumors Drugs Revenue and Share by Manufacturers (2015 and 2016)

2.2 Europe Solid Tumors Drugs (Volume and Value) by Type

2.2.1 Europe Solid Tumors Drugs Sales and Market Share by Type (2011-2016)

2.2.2 Europe Solid Tumors Drugs Revenue and Market Share by Type (2011-2016)

2.3 Europe Solid Tumors Drugs (Volume and Value) by Countries

2.3.1 Europe Solid Tumors Drugs Sales and Market Share by Countries (2011-2016)

2.3.2 Europe Solid Tumors Drugs Revenue and Market Share by Countries (2011-2016)

2.4 Europe Solid Tumors Drugs (Volume) by Application

3 Germany Solid Tumors Drugs (Volume, Value and Sales Price)

3.1 Germany Solid Tumors Drugs Sales and Value (2011-2016)

3.1.1 Germany Solid Tumors Drugs Sales and Growth Rate (2011-2016)

3.1.2 Germany Solid Tumors Drugs Revenue and Growth Rate (2011-2016)

3.1.3 Germany Solid Tumors Drugs Sales Price Trend (2011-2016)

3.2 Germany Solid Tumors Drugs Sales and Market Share by Manufacturers

3.3 Germany Solid Tumors Drugs Sales and Market Share by Type

3.4 Germany Solid Tumors Drugs Sales and Market Share by Application

4 France Solid Tumors Drugs (Volume, Value and Sales Price)

4.1 France Solid Tumors Drugs Sales and Value (2011-2016)

4.1.1 France Solid Tumors Drugs Sales and Growth Rate (2011-2016)

4.1.2 France Solid Tumors Drugs Revenue and Growth Rate (2011-2016)

4.1.4 France Solid Tumors Drugs Sales Price Trend (2011-2016)

4.2 France Solid Tumors Drugs Sales and Market Share by Manufacturers

4.3 France Solid Tumors Drugs Sales and Market Share by Type

4.4 France Solid Tumors Drugs Sales and Market Share by Application

5 UK Solid Tumors Drugs (Volume, Value and Sales Price)

5.1 UK Solid Tumors Drugs Sales and Value (2011-2016)

5.1.1 UK Solid Tumors Drugs Sales and Growth Rate (2011-2016)

5.1.2 UK Solid Tumors Drugs Revenue and Growth Rate (2011-2016)

5.1.5 UK Solid Tumors Drugs Sales Price Trend (2011-2016)

5.2 UK Solid Tumors Drugs Sales and Market Share by Manufacturers

5.3 UK Solid Tumors Drugs Sales and Market Share by Type

5.4 UK Solid Tumors Drugs Sales and Market Share by Application

6 Russia Solid Tumors Drugs (Volume, Value and Sales Price)

6.1 Russia Solid Tumors Drugs Sales and Value (2011-2016)

6.1.1 Russia Solid Tumors Drugs Sales and Growth Rate (2011-2016)

6.1.2 Russia Solid Tumors Drugs Revenue and Growth Rate (2011-2016)

6.1.6 Russia Solid Tumors Drugs Sales Price Trend (2011-2016)

6.2 Russia Solid Tumors Drugs Sales and Market Share by Manufacturers

6.3 Russia Solid Tumors Drugs Sales and Market Share by Type

6.4 Russia Solid Tumors Drugs Sales and Market Share by Application

7 Italy Solid Tumors Drugs (Volume, Value and Sales Price)

7.1 Italy Solid Tumors Drugs Sales and Value (2011-2016)

7.1.1 Italy Solid Tumors Drugs Sales and Growth Rate (2011-2016)

7.1.2 Italy Solid Tumors Drugs Revenue and Growth Rate (2011-2016)

7.1.7 Italy Solid Tumors Drugs Sales Price Trend (2011-2016)

7.2 Italy Solid Tumors Drugs Sales and Market Share by Manufacturers

7.3 Italy Solid Tumors Drugs Sales and Market Share by Type

7.4 Italy Solid Tumors Drugs Sales and Market Share by Application

8 Spain Solid Tumors Drugs (Volume, Value and Sales Price)

8.1 Spain Solid Tumors Drugs Sales and Value (2011-2016)

8.1.1 Spain Solid Tumors Drugs Sales and Growth Rate (2011-2016)

8.1.2 Spain Solid Tumors Drugs Revenue and Growth Rate (2011-2016)

8.1.8 Spain Solid Tumors Drugs Sales Price Trend (2011-2016)

8.2 Spain Solid Tumors Drugs Sales and Market Share by Manufacturers

8.3 Spain Solid Tumors Drugs Sales and Market Share by Type

8.4 Spain Solid Tumors Drugs Sales and Market Share by Application

9 Benelux Solid Tumors Drugs (Volume, Value and Sales Price)

9.1 Benelux Solid Tumors Drugs Sales and Value (2011-2016)

9.1.1 Benelux Solid Tumors Drugs Sales and Growth Rate (2011-2016)

9.1.2 Benelux Solid Tumors Drugs Revenue and Growth Rate (2011-2016)

9.1.9 Benelux Solid Tumors Drugs Sales Price Trend (2011-2016)

9.2 Benelux Solid Tumors Drugs Sales and Market Share by Manufacturers

9.3 Benelux Solid Tumors Drugs Sales and Market Share by Type

9.4 Benelux Solid Tumors Drugs Sales and Market Share by Application

10 Europe Solid Tumors Drugs Manufacturers Analysis

10.1 Covidien llc (Medtronic)

10.1.1 Company Basic Information, Manufacturing Base and Competitors

10.1.2 Solid Tumors Drugs Product Type, Application and Specification

10.1.2.1 Type I

10.1.2.2 Type II

10.1.3 Covidien llc (Medtronic) Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.1.4 Main Business/Business Overview

10.2 Johnson & Johnson MEDICAL

10.2.1 Company Basic Information, Manufacturing Base and Competitors

10.2.2 Solid Tumors Drugs Product Type, Application and Specification

10.2.2.1 Type I

10.2.2.2 Type II

10.2.3 Johnson & Johnson MEDICAL Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.2.4 Main Business/Business Overview

10.3 Bolton Surgical

10.3.1 Company Basic Information, Manufacturing Base and Competitors

10.3.2 Solid Tumors Drugs Product Type, Application and Specification

10.3.2.1 Type I

10.3.2.2 Type II

10.3.3 Bolton Surgical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.3.4 Main Business/Business Overview

10.4 Platts & Nisbett

10.4.1 Company Basic Information, Manufacturing Base and Competitors

10.4.2 Solid Tumors Drugs Product Type, Application and Specification

10.4.2.1 Type I

10.4.2.2 Type II

10.4.3 Platts & Nisbett Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.4.4 Main Business/Business Overview

10.5 Frankenman International

10.5.1 Company Basic Information, Manufacturing Base and Competitors

10.5.2 Solid Tumors Drugs Product Type, Application and Specification

10.5.2.1 Type I

10.5.2.2 Type II

10.5.3 Frankenman International Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.5.4 Main Business/Business Overview

10.6 Changzhou Waston

10.6.1 Company Basic Information, Manufacturing Base and Competitors

10.6.2 Solid Tumors Drugs Product Type, Application and Specification

10.6.2.1 Type I

10.6.2.2 Type II

10.6.3 Changzhou Waston Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.6.4 Main Business/Business Overview

10.7 Jiangsu Qianjing Medical

10.7.1 Company Basic Information, Manufacturing Base and Competitors

10.7.2 Solid Tumors Drugs Product Type, Application and Specification

10.7.2.1 Type I

10.7.2.2 Type II

10.7.3 Jiangsu Qianjing Medical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.7.4 Main Business/Business Overview

10.8 Changzhou Anker Medical

10.8.1 Company Basic Information, Manufacturing Base and Competitors

10.8.2 Solid Tumors Drugs Product Type, Application and Specification

10.8.2.1 Type I

10.8.2.2 Type II

10.8.3 Changzhou Anker Medical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.8.4 Main Business/Business Overview

10.9 Changzhou Tongchuang Medical

10.9.1 Company Basic Information, Manufacturing Base and Competitors

10.9.2 Solid Tumors Drugs Product Type, Application and Specification

10.9.2.1 Type I

10.9.2.2 Type II

10.9.3 Changzhou Tongchuang Medical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.9.4 Main Business/Business Overview

10.10 Jiangsu Reable Medical

10.10.1 Company Basic Information, Manufacturing Base and Competitors

10.10.2 Solid Tumors Drugs Product Type, Application and Specification

10.10.2.1 Type I

10.10.2.2 Type II

10.10.3 Jiangsu Reable Medical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

10.10.4 Main Business/Business Overview

10.11 Changzhou Resource Medical

10.12 Jiangsu Kangjin Medical

10.13 CTI BioPharma

10.14 Chugai Pharmaceutical

10.15 NewLink Genetics

11 Solid Tumors Drugs Manufacturing Cost Analysis

11.1 Solid Tumors Drugs Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Solid Tumors Drugs

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Solid Tumors Drugs Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Solid Tumors Drugs Major Manufacturers in 2015

12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List

14 Europe Solid Tumors Drugs Market Forecast (2016-2021)

14.1 Germany Solid Tumors Drugs Sales Forecast (2016-2021)

14.2 France Solid Tumors Drugs Sales Forecast (2016-2021)

14.3 UK Solid Tumors Drugs Sales Forecast (2016-2021)

14.4 Russia Solid Tumors Drugs Sales Forecast (2016-2021)

14.5 Italy Solid Tumors Drugs Sales Forecast (2016-2021)

14.6 Spain Solid Tumors Drugs Sales Forecast (2016-2021)

14.7 Benelux Solid Tumors Drugs Sales Forecast (2016-2021)

14.8 Europe Solid Tumors Drugs Sales Forecast by Type (2016-2021)

14.9 Europe Solid Tumors Drugs Sales Forecast by Application (2016-2021)

15 Research Findings and Conclusion

16 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

Figure Picture of Solid Tumors Drugs

Table Classification of Solid Tumors Drugs

Figure Europe Sales Market Share of Solid Tumors Drugs by Type in 2015

Figure Type I Picture

Figure Type II Picture

Table Application of Solid Tumors Drugs

Figure Europe Sales Market Share of Solid Tumors Drugs by Application in 2015

Figure Application 1 Examples

Figure Application 2 Examples

Figure Germany Solid Tumors Drugs Revenue and Growth Rate (2011-2021)

Figure France Solid Tumors Drugs Revenue and Growth Rate (2011-2021)

Figure UK Solid Tumors Drugs Revenue and Growth Rate (2011-2021)

Figure Russia Solid Tumors Drugs Revenue and Growth Rate (2011-2021)

Figure Italy Solid Tumors Drugs Revenue and Growth Rate (2011-2021)

Figure Spain Solid Tumors Drugs Revenue and Growth Rate (2011-2021)

Figure Benelux Solid Tumors Drugs Revenue and Growth Rate (2011-2021)

Figure Europe Solid Tumors Drugs Sales and Growth Rate (2011-2021)

Figure Europe Solid Tumors Drugs Revenue and Growth Rate (2011-2021)

Table Europe Solid Tumors Drugs Sales of Key Manufacturers (2015 and 2016)

Table Europe Solid Tumors Drugs Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Solid Tumors Drugs Sales Share by Manufacturers

Figure 2016 Solid Tumors Drugs Sales Share by Manufacturers

Table Europe Solid Tumors Drugs Revenue by Manufacturers (2015 and 2016)

Table Europe Solid Tumors Drugs Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe Solid Tumors Drugs Revenue Share by Manufacturers

Table 2016 Europe Solid Tumors Drugs Revenue Share by Manufacturers

Table Europe Solid Tumors Drugs Sales and Market Share by Type (2011-2016)

Table Europe Solid Tumors Drugs Sales Share by Type (2011-2016)

Figure Sales Market Share of Solid Tumors Drugs by Type (2011-2016)

Figure Europe Solid Tumors Drugs Sales Growth Rate by Type (2011-2016)

Table Europe Solid Tumors Drugs Revenue and Market Share by Type (2011-2016)

Table Europe Solid Tumors Drugs Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Solid Tumors Drugs by Type (2011-2016)

Figure Europe Solid Tumors Drugs Revenue Growth Rate by Type (2011-2016)

Table Europe Solid Tumors Drugs Sales and Market Share by Countries (2011-2016)

Table Europe Solid Tumors Drugs Sales Share by Countries (2011-2016)

Figure Sales Market Share of Solid Tumors Drugs by Countries (2011-2016)

Table Europe Solid Tumors Drugs Revenue and Market Share by Countries (2011-2016)

Table Europe Solid Tumors Drugs Revenue Share by Countries (2011-2016)

Figure Revenue Market Share of Solid Tumors Drugs by Countries (2011-2016)

Table Europe Solid Tumors Drugs Sales and Market Share by Application (2011-2016)

Table Europe Solid Tumors Drugs Sales Share by Application (2011-2016)

Figure Sales Market Share of Solid Tumors Drugs by Application (2011-2016)

Figure Germany Solid Tumors Drugs Sales and Growth Rate (2011-2016)

Figure Germany Solid Tumors Drugs Revenue and Growth Rate (2011-2016)

Figure Germany Solid Tumors Drugs Sales Price Trend (2011-2016)

Table Germany Solid Tumors Drugs Sales by Manufacturers (2015 and 2016)

Table Germany Solid Tumors Drugs Market Share by Manufacturers (2015 and 2016)

Table Germany Solid Tumors Drugs Sales by Type (2015 and 2016)

Table Germany Solid Tumors Drugs Market Share by Type (2015 and 2016)

Table Germany Solid Tumors Drugs Sales by Application (2015 and 2016)

Table Germany Solid Tumors Drugs Market Share by Application (2015 and 2016)

Figure France Solid Tumors Drugs Sales and Growth Rate (2011-2016)

Figure France Solid Tumors Drugs Revenue and Growth Rate (2011-2016)

Figure France Solid Tumors Drugs Sales Price Trend (2011-2016)

Table France Solid Tumors Drugs Sales by Manufacturers (2015 and 2016)

Table France Solid Tumors Drugs Market Share by Manufacturers (2015 and 2016)

Table France Solid Tumors Drugs Sales by Type (2015 and 2016)

Table France Solid Tumors Drugs Market Share by Type (2015 and 2016)

Table France Solid Tumors Drugs Sales by Application (2015 and 2016)

Table France Solid Tumors Drugs Market Share by Application (2015 and 2016)

Figure UK Solid Tumors Drugs Sales and Growth Rate (2011-2016)

Figure UK Solid Tumors Drugs Revenue and Growth Rate (2011-2016)

Figure UK Solid Tumors Drugs Sales Price Trend (2011-2016)

Table UK Solid Tumors Drugs Sales by Manufacturers (2015 and 2016)

Table UK Solid Tumors Drugs Market Share by Manufacturers (2015 and 2016)

Table UK Solid Tumors Drugs Sales by Type (2015 and 2016)

Table UK Solid Tumors Drugs Market Share by Type (2015 and 2016)

Table UK Solid Tumors Drugs Sales by Application (2015 and 2016)

Table UK Solid Tumors Drugs Market Share by Application (2015 and 2016)

Figure Russia Solid Tumors Drugs Sales and Growth Rate (2011-2016)

Figure Russia Solid Tumors Drugs Revenue and Growth Rate (2011-2016)

Figure Russia Solid Tumors Drugs Sales Price Trend (2011-2016)

Table Russia Solid Tumors Drugs Sales by Manufacturers (2015 and 2016)

Table Russia Solid Tumors Drugs Market Share by Manufacturers (2015 and 2016)

Table Russia Solid Tumors Drugs Sales by Type (2015 and 2016)

Table Russia Solid Tumors Drugs Market Share by Type (2015 and 2016)

Table Russia Solid Tumors Drugs Sales by Application (2015 and 2016)

Table Russia Solid Tumors Drugs Market Share by Application (2015 and 2016)

Figure Italy Solid Tumors Drugs Sales and Growth Rate (2011-2016)

Figure Italy Solid Tumors Drugs Revenue and Growth Rate (2011-2016)

Figure Italy Solid Tumors Drugs Sales Price Trend (2011-2016)

Table Italy Solid Tumors Drugs Sales by Manufacturers (2015 and 2016)

Table Italy Solid Tumors Drugs Market Share by Manufacturers (2015 and 2016)

Table Italy Solid Tumors Drugs Sales by Type (2015 and 2016)

Table Italy Solid Tumors Drugs Market Share by Type (2015 and 2016)

Table Italy Solid Tumors Drugs Sales by Application (2015 and 2016)

Table Italy Solid Tumors Drugs Market Share by Application (2015 and 2016)

Figure Spain Solid Tumors Drugs Sales and Growth Rate (2011-2016)

Figure Spain Solid Tumors Drugs Revenue and Growth Rate (2011-2016)

Figure Spain Solid Tumors Drugs Sales Price Trend (2011-2016)

Table Spain Solid Tumors Drugs Sales by Manufacturers (2015 and 2016)

Table Spain Solid Tumors Drugs Market Share by Manufacturers (2015 and 2016)

Table Spain Solid Tumors Drugs Sales by Type (2015 and 2016)

Table Spain Solid Tumors Drugs Market Share by Type (2015 and 2016)

Table Spain Solid Tumors Drugs Sales by Application (2015 and 2016)

Table Spain Solid Tumors Drugs Market Share by Application (2015 and 2016)

Figure Benelux Solid Tumors Drugs Sales and Growth Rate (2011-2016)

Figure Benelux Solid Tumors Drugs Revenue and Growth Rate (2011-2016)

Figure Benelux Solid Tumors Drugs Sales Price Trend (2011-2016)

Table Benelux Solid Tumors Drugs Sales by Manufacturers (2015 and 2016)

Table Benelux Solid Tumors Drugs Market Share by Manufacturers (2015 and 2016)

Table Benelux Solid Tumors Drugs Sales by Type (2015 and 2016)

Table Benelux Solid Tumors Drugs Market Share by Type (2015 and 2016)

Table Benelux Solid Tumors Drugs Sales by Application (2015 and 2016)

Table Benelux Solid Tumors Drugs Market Share by Application (2015 and 2016)

Table Solid Tumors Drugs Basic Information List

Table Covidien llc (Medtronic) Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Covidien llc (Medtronic) Solid Tumors Drugs Sales Market Share (2011-2016)

Table Johnson & Johnson MEDICAL Basic Information List

Table Johnson & Johnson MEDICAL Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Johnson & Johnson MEDICAL Solid Tumors Drugs Sales Market Share (2011-2016)

Table Bolton Surgical Basic Information List

Table Bolton Surgical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bolton Surgical Solid Tumors Drugs Sales Market Share (2011-2016)

Table Platts & Nisbett Basic Information List

Table Platts & Nisbett Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Platts & Nisbett Solid Tumors Drugs Sales Market Share (2011-2016)

Table Frankenman International Basic Information List

Table Frankenman International Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Frankenman International Solid Tumors Drugs Sales Market Share (2011-2016)

Table Changzhou Waston Basic Information List

Table Changzhou Waston Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Changzhou Waston Solid Tumors Drugs Sales Market Share (2011-2016)

Table Jiangsu Qianjing Medical Basic Information List

Table Jiangsu Qianjing Medical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Jiangsu Qianjing Medical Solid Tumors Drugs Sales Market Share (2011-2016)

Table Changzhou Anker Medical Basic Information List

Table Changzhou Anker Medical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Changzhou Anker Medical Solid Tumors Drugs Sales Market Share (2011-2016)

Table Changzhou Tongchuang Medical Basic Information List

Table Changzhou Tongchuang Medical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Changzhou Tongchuang Medical Solid Tumors Drugs Sales Market Share (2011-2016)

Table Jiangsu Reable Medical Basic Information List

Table Jiangsu Reable Medical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Jiangsu Reable Medical Solid Tumors Drugs Sales Market Share (2011-2016)

Table Changzhou Resource Medical Basic Information List

Table Changzhou Resource Medical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Changzhou Resource Medical Solid Tumors Drugs Sales Market Share (2011-2016)

Table Jiangsu Kangjin Medical Basic Information List

Table Jiangsu Kangjin Medical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Jiangsu Kangjin Medical Solid Tumors Drugs Sales Market Share (2011-2016)

Table CTI BioPharma Basic Information List

Table CTI BioPharma Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table CTI BioPharma Solid Tumors Drugs Sales Market Share (2011-2016)

Table Chugai Pharmaceutical Basic Information List

Table Chugai Pharmaceutical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Chugai Pharmaceutical Solid Tumors Drugs Sales Market Share (2011-2016)

Table NewLink Genetics Basic Information List

Table NewLink Genetics Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table NewLink Genetics Solid Tumors Drugs Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Solid Tumors Drugs

Figure Manufacturing Process Analysis of Solid Tumors Drugs

Figure Solid Tumors Drugs Industrial Chain Analysis

Table Raw Materials Sources of Solid Tumors Drugs Major Manufacturers in 2015

Table Major Buyers of Solid Tumors Drugs

Table Distributors/Traders List

Figure Germany Solid Tumors Drugs Sales and Growth Rate Forecast (2016-2021)

Figure Germany Solid Tumors Drugs Revenue and Growth Rate Forecast (2016-2021)

Figure France Solid Tumors Drugs Sales and Growth Rate Forecast (2016-2021)

Figure France Solid Tumors Drugs Revenue and Growth Rate Forecast (2016-2021)

Figure UK Solid Tumors Drugs Sales and Growth Rate Forecast (2016-2021)

Figure UK Solid Tumors Drugs Revenue and Growth Rate Forecast (2016-2021)

Figure Russia Solid Tumors Drugs Sales and Growth Rate Forecast (2016-2021)

Figure Russia Solid Tumors Drugs Revenue and Growth Rate Forecast (2016-2021)

Figure Italy Solid Tumors Drugs Sales and Growth Rate Forecast (2016-2021)

Figure Italy Solid Tumors Drugs Revenue and Growth Rate Forecast (2016-2021)

Figure Spain Solid Tumors Drugs Sales and Growth Rate Forecast (2016-2021)

Figure Spain Solid Tumors Drugs Revenue and Growth Rate Forecast (2016-2021)

Figure Benelux Solid Tumors Drugs Sales and Growth Rate Forecast (2016-2021)

Figure Benelux Solid Tumors Drugs Revenue and Growth Rate Forecast (2016-2021)

Table Europe Solid Tumors Drugs Sales Forecast by Type (2016-2021)

Table Europe Solid Tumors Drugs Sales Forecast by Application (2016-2021)